首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer
【24h】

Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer

机译:循环microRNA-1290作为人类大肠癌的新型诊断和预后生物标志物

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Our comprehensive miRNA microarray analyses identify the serum miRNA expression profiles differed significantly between controls and adenoma or CRC. Especially, miR-1290 expression is most statistically up-regulated in serum samples from adenoma or CRC patients versus controls, and is a promising, serum-based non-invasive biomarker for the detection and prognosis of colorectal neoplasia.Circulating microRNAs (miRNAs) are attracting major interest as potential non-invasive biomarkers for colorectal cancer (CRC). This study aimed to identify a novel serum miRNA biomarker for the early detection and/or evaluating prognosis of CRC patients.
机译:我们全面的miRNA微阵列分析可确定对照组和腺瘤或CRC之间的血清miRNA表达谱存在显着差异。特别是,在腺瘤或CRC患者的血清样品中与对照相比,miR-1290的表达在统计学上最上调,并且是有希望的基于血清的非侵入性生物标记物,可用于检测和预后结直肠肿瘤。循环microRNA(miRNA)是作为结直肠癌(CRC)潜在的非侵入性生物标记物,引起了广泛的关注。这项研究旨在确定一种新型的血清miRNA生物标记物,用于CRC患者的早期检测和/或评估预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号